What is Groove Botanical's earnings per share (EPS)?

Groove Botanical (GRVE) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Groove Botanical Financials

GRVE

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE March

This page shows Groove Botanical (GRVE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Groove Botanical's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

100

Groove Botanical carries a low D/E ratio of -1.00, meaning only $-1.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Groove Botanical's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.01

YoY+0.0%

Groove Botanical earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$2K

YoY+21.0%

5Y CAGR-56.8%

Groove Botanical held $2K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

60M

YoY+0.0%

Groove Botanical had 60M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GRVE Income Statement

Metric	FY25	FY24	FY23	FY17	FY16	FY15
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	$184K-76.7%	$789K+176.3%	$286K
Operating Income	N/A	N/A	N/A	-$237K	N/A	-$374K
Interest Expense	N/A	N/A	N/A	-$12K-168.9%	$17K-61.2%	$43K
Income Tax	N/A	N/A	N/A	N/A	$0	$0
Net Income	N/A	N/A	N/A	-$243K	N/A	$100K
EPS (Diluted)	$-0.010.0%	$-0.01	$0.00	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$16K-2.9%	$17K	N/A	N/A	$17K-5.9%	$18K	N/A	N/A
Operating Income	N/A	-$32K	N/A	N/A	N/A	-$30K	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$32K	N/A	N/A	N/A	-$30K	N/A	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

GRVE Balance Sheet

Metric	FY25	FY24	FY23	FY17	FY16	FY15
Total Assets	$5K+111.0%	$2K-57.6%	$5K-98.4%	$325K-13.0%	$374K-86.4%	$2.7M
Current Assets	$5K+111.0%	$2K-57.6%	$5K-95.2%	$105K-3.4%	$108K-81.0%	$569K
Cash & Equivalents	$2K+21.0%	$2K-63.0%	$5K-95.6%	$105K-3.4%	$108K-20.3%	$136K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	$25	N/A	$0-100.0%	$33K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.1M+46.1%	$763K+72.0%	$443K-66.6%	$1.3M+43.9%	$921K-12.8%	$1.1M
Current Liabilities	$1.1M+46.1%	$763K+72.0%	$443K-57.5%	$1.0M+32.8%	$785K-15.9%	$933K
Long-Term Debt	N/A	N/A	N/A	N/A	$149K	$0
Total Equity	-$1.1M-45.9%	-$761K-73.5%	-$438K+56.2%	-$1.0M-67.1%	-$598K-135.4%	$1.7M
Retained Earnings	-$35.2M-1.0%	-$34.8M-1.2%	-$34.4M-1.2%	-$34.0M-1.2%	-$33.6M-8.8%	-$30.9M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$6K-23.3%	$8K+121.5%	$4K-18.5%	$5K-4.5%	$5K-57.5%	$11K+264.3%	$3K+42.6%	$2K
Current Assets	$6K-23.3%	$8K+121.5%	$4K-18.5%	$5K-4.5%	$5K-57.5%	$11K+264.3%	$3K+42.6%	$2K
Cash & Equivalents	$1K+0.1%	$1K-45.5%	$3K+34.0%	$2K+63.2%	$1K-79.6%	$6K+132.5%	$3K+56.3%	$2K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.4M+6.7%	$1.3M+7.6%	$1.2M+8.3%	$1.1M+8.3%	$1.0M+8.6%	$947K+10.8%	$855K+12.1%	$763K
Current Liabilities	$1.4M+6.7%	$1.3M+7.6%	$1.2M+8.3%	$1.1M+8.3%	$1.0M+8.6%	$947K+10.8%	$855K+12.1%	$763K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.4M-6.9%	-$1.3M-7.2%	-$1.2M-8.4%	-$1.1M-8.4%	-$1.0M-9.4%	-$936K-9.9%	-$852K-12.0%	-$761K
Retained Earnings	-$35.5M-0.3%	-$35.4M-0.2%	-$35.3M-0.3%	-$35.2M-0.2%	-$35.1M-0.3%	-$35.0M-0.2%	-$34.9M-0.3%	-$34.8M

GRVE Cash Flow Statement

Metric	FY25	FY24	FY23	FY17	FY16	FY15
Operating Cash Flow	N/A	N/A	N/A	-$104K+70.3%	-$349K-51.5%	-$230K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	$1K+101.3%	-$113K
Financing Cash Flow	N/A	N/A	N/A	$100K-68.8%	$320K+25.5%	$255K
Dividends Paid	N/A	N/A	N/A	N/A	$0-100.0%	$65K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$20K+44.3%	-$36K	N/A	-$18K	N/A	-$43K	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$20K-42.3%	$35K	N/A	$19K-10.0%	$21K-54.6%	$46K	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GRVE Financial Ratios

Metric	FY25	FY24	FY23	FY17	FY16	FY15
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	5.9%
Return on Assets	N/A	N/A	N/A	-74.8%	N/A	3.6%
Current Ratio	0.000.0	0.000.0	0.01-0.1	0.10-0.0	0.14-0.5	0.61
Debt-to-Equity	-1.000.0	-1.000.0	-1.01+0.3	-1.33-1.1	-0.25-0.2	0.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-396.7%	N/A	N/A	N/A	-268.2%	N/A	N/A
Current Ratio	0.000.0	0.010.0	0.000.0	0.000.0	0.000.0	0.010.0	0.000.0	0.00
Debt-to-Equity	-1.000.0	-1.010.0	-1.000.0	-1.000.0	-1.000.0	-1.010.0	-1.000.0	-1.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Orpheum Ppty Inc PLFF

$270K

New Frontier Energy Inc NFEI

$383K

Mondial Ventu MNVN

$198K

Reostar Energy REOS

$2.7M

Quest Oil QOIL

$150K

Frequently Asked Questions

What are Groove Botanical's total assets?

Groove Botanical (GRVE) had $5K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Groove Botanical have outstanding?

Groove Botanical (GRVE) had 60M shares outstanding as of fiscal year 2025.

What is Groove Botanical's current ratio?

Groove Botanical (GRVE) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Groove Botanical's debt-to-equity ratio?

Groove Botanical (GRVE) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Groove Botanical's debt-to-equity ratio negative or unusual?

Groove Botanical (GRVE) has negative shareholder equity of -$1.1M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Groove Botanical?

Groove Botanical (GRVE) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.